Literature DB >> 20408906

When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits.

Laurence Garey1.   

Abstract

Schizophrenia probably has a developmental origin. This review refers to three of our published series of studies related to this hypothesis: loss of dendritic spines on cerebral neocortical pyramidal neurons, decreased numerical density of glutamatergic neurons, and microgliosis. First, brains of schizophrenic patients and non-schizophrenic controls were obtained post mortem and blocks of multiple cortical areas impregnated with a Rapid Golgi method. Spines were counted on the dendrites of pyramidal neurons of which the soma was in layer III (which takes part in corticocortical connectivity) and which met strict criteria for impregnation quality. Data were obtained blind: diagnoses were only revealed by a third party after measurements were completed. The mean spine count in all cortical areas studied in the control series was 243 mm(-1) of dendrite and in the schizophrenics 108. Measurements in frontal and temporal association cortex showed the greatest reduction in spine number in schizophrenia (299 in control frontal cortex and 101 in schizophrenics, and 276 mm(-1) in control temporal cortex and 125 in schizophrenics). There was no correlation of spine loss with age at death. Our results support the concept of a neurodevelopmental defect in the neuropil affecting glutamatergic neurons in schizophrenia and may help to explain loss of cortical volume without loss of neurons. In a second part of our study we used an antibody to the kainate receptor subunit GluR 5/6/7 and showed a decrease in numerical density of presumed glutamatergic neurons in schizophrenic orbitofrontal cortex. Finally, as glia play a major role in the developing nervous system, we investigated whether schizophrenia was associated with glial changes in frontal and temporal cortex. Astroglia and microglia were identified in schizophrenic and control brains, using antibodies to glial fibrillary acidic protein (GFAP) and class II human leucocyte antigen (HLA-DR), respectively. Significant increases were found in microglial numerical density in schizophrenics compared with controls: 28% in frontal area 9 (115 cells mm(-2) compared with 89), and a 57% increase in temporal area 22 (139 cells mm(-2) compared with 88). For both areas, astroglia showed no significant differences between schizophrenics and controls. No significant differences were found in cortical thickness or total neuronal numerical density between the two groups. This specific increase in numerical density of microglia in temporal and frontal cortex of chronic schizophrenics, not related to aging, could be related to possible changes in cortical neuropil architecture as revealed by loss of dendritic spines.
© 2010 The Author. Journal of Anatomy © 2010 Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2010        PMID: 20408906      PMCID: PMC2992411          DOI: 10.1111/j.1469-7580.2010.01231.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  76 in total

1.  Prenatal development of neurons in the human prefrontal cortex. II. A quantitative Golgi study.

Authors:  L Mrzljak; H B Uylings; I Kostovic; C G van Eden
Journal:  J Comp Neurol       Date:  1992-02-22       Impact factor: 3.215

2.  Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.

Authors:  P J Harrison; D McLaughlin; R W Kerwin
Journal:  Lancet       Date:  1991-02-23       Impact factor: 79.321

Review 3.  Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.

Authors:  Maxwell Bennett
Journal:  Aust N Z J Psychiatry       Date:  2009-08       Impact factor: 5.744

4.  Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics.

Authors:  Teresa Wierzba-Bobrowicz; Eliza Lewandowska; Waldemar Lechowicz; Tomasz Stepień; Elzbieta Pasennik
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

5.  Cerebral ventricular size in twins discordant for schizophrenia.

Authors:  A M Reveley; M A Reveley; C A Clifford; R M Murray
Journal:  Lancet       Date:  1982-03-06       Impact factor: 79.321

6.  [Long-term chlorpromazine therapy in animal experiments].

Authors:  H Sommer; J Quandt
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1970-09

7.  Decreased numbers of dendritic spines on cortical pyramidal neurons in dementia. A quantitative Golgi study on biopsy samples.

Authors:  I Catalá; I Ferrer; E Galofré; I Fábregues
Journal:  Hum Neurobiol       Date:  1988

8.  Prenatal development of parvalbumin immunoreactivity in the human striate cortex.

Authors:  Q L Cao; X X Yan; X G Luo; L J Garey
Journal:  Cereb Cortex       Date:  1996 Jul-Aug       Impact factor: 5.357

9.  Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex.

Authors:  J F Smiley; S M Williams; K Szigeti; P S Goldman-Rakic
Journal:  J Comp Neurol       Date:  1992-07-15       Impact factor: 3.215

10.  Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia.

Authors:  A Pfefferbaum; R B Zipursky; K O Lim; L M Zatz; S M Stahl; T L Jernigan
Journal:  Arch Gen Psychiatry       Date:  1988-07
View more
  61 in total

Review 1.  Searching for neuropathology: gliosis in schizophrenia.

Authors:  Tatiana P Schnieder; Andrew J Dwork
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

Review 2.  Post-transcriptional regulatory elements and spatiotemporal specification of neocortical stem cells and projection neurons.

Authors:  E M DeBoer; M L Kraushar; R P Hart; M-R Rasin
Journal:  Neuroscience       Date:  2013-05-30       Impact factor: 3.590

Review 3.  Opportunities and challenges for using the zebrafish to study neuronal connectivity as an endpoint of developmental neurotoxicity.

Authors:  Galen W Miller; Vidya Chandrasekaran; Bianca Yaghoobi; Pamela J Lein
Journal:  Neurotoxicology       Date:  2018-04-25       Impact factor: 4.294

4.  Associations of cortical thickness and cognition in patients with schizophrenia and healthy controls.

Authors:  Stefan Ehrlich; Stefan Brauns; Anastasia Yendiki; Beng-Choon Ho; Vince Calhoun; S Charles Schulz; Randy L Gollub; Scott R Sponheim
Journal:  Schizophr Bull       Date:  2011-03-24       Impact factor: 9.306

Review 5.  Valid statistical approaches for analyzing sholl data: Mixed effects versus simple linear models.

Authors:  Machelle D Wilson; Sunjay Sethi; Pamela J Lein; Kimberly P Keil
Journal:  J Neurosci Methods       Date:  2017-01-16       Impact factor: 2.390

6.  Abnormal synaptic pruning in schizophrenia: Urban myth or reality?

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

7.  Detection of 3,3'-Dichlorobiphenyl in Human Maternal Plasma and Its Effects on Axonal and Dendritic Growth in Primary Rat Neurons.

Authors:  Sunjay Sethi; Kimberly P Keil; Hao Chen; Keri Hayakawa; Xueshu Li; Yanping Lin; Hans-Joachim Lehmler; Birgit Puschner; Pamela J Lein
Journal:  Toxicol Sci       Date:  2017-08-01       Impact factor: 4.849

Review 8.  Age, plasticity, and homeostasis in childhood brain disorders.

Authors:  Maureen Dennis; Brenda J Spiegler; Jenifer J Juranek; Erin D Bigler; O Carter Snead; Jack M Fletcher
Journal:  Neurosci Biobehav Rev       Date:  2013-10-03       Impact factor: 8.989

9.  The environmental neurotoxicant PCB 95 promotes synaptogenesis via ryanodine receptor-dependent miR132 upregulation.

Authors:  Adam Lesiak; Mingyan Zhu; Hao Chen; Suzanne M Appleyard; Soren Impey; Pamela J Lein; Gary A Wayman
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  Automated high content image analysis of dendritic arborization in primary mouse hippocampal and rat cortical neurons in culture.

Authors:  Martin R Schmuck; Kimberly P Keil; Sunjay Sethi; Rhianna K Morgan; Pamela J Lein
Journal:  J Neurosci Methods       Date:  2020-05-24       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.